Seulki Park
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK.
Journal: Journal of medicinal chemistry
Published: June 16, 2026
Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder.
Journal: European journal of medicinal chemistry
Published: January 14, 2025
Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers.
Journal: Bioorganic & medicinal chemistry letters
Published: January 06, 2025
Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle.
Journal: Bioorganic & medicinal chemistry letters
Published: August 21, 2024
Hypoxia stabilizes SETDB1 to maintain genome stability.
Journal: Nucleic acids research
Published: October 01, 2022
Discovery of pan-IAP degraders via a CRBN recruiting mechanism.
Journal: European journal of medicinal chemistry
Published: September 08, 2022
Artificial intelligence-based identification of octenidine as a Bcl-xL inhibitor.
Journal: Biochemical and biophysical research communications
Published: November 24, 2021
miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma.
Journal: Scientific reports
Published: September 14, 2021
Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells.
Journal: BMB reports
Published: October 05, 2020
The Tumor Suppressor, p53, Negatively Regulates Non-Canonical NF-κB Signaling through miRNAInduced Silencing of NF-κB-Inducing Kinase.
Journal: Molecules and cells
Published: October 22, 2019
RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.
Journal: Cell death & disease
Published: January 03, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026